방사선생물학

본문글자크기
  • [Carcinogenesis.] SMAD7 in keratinocytes promotes skin carcinogenesis by activating ATM-dependent DNA repair and an EGFR-mediated cell proliferation pathway.SMAD7에 의한 DNA 손상회복능촉진 및 EGFR 활성화로 유도되는 피부암 발병 기능 연구

    가천의대 / Huyen Trang Ha Thi, 홍선택*

  • 출처
    Carcinogenesis.
  • 등재일
    2019 Mar 12
  • 저널이슈번호
    40(1):112-120. doi: 10.1093/carcin/bgy121.
  • 내용

    바로가기  >

    Abstract
    SMA- and MAD-related protein 7 (SMAD7) is a general inhibitor of transforming growth factor-β (TGF-β) signaling that acts through interaction and degradation of TGF-β receptors. SMAD7 has been demonstrated to be transcriptionally upregulated in chemical-induced skin tumors and TGF-β-treated normal keratinocytes. To evaluate the function of SMAD7 in skin carcinogenesis in vivo, Smad7 transgenic mice that specifically express either wild-type (WT) SMAD7 (TG-Smad7-WT) or mutant SMAD7 (TG-Smad7-MT) in keratinocytes, as well as Smad7 keratinocyte-specific knockout (Smad72f/2f-K14Cre) mice, were subjected to chemical-induced skin carcinogenesis. WT-SMAD7-expressing transgenic mice showed significantly greater papilloma formation than did non-TG control and Smad7-MT mice. The expression of WT-SMAD7 attenuated DNA damage-induced apoptosis in epidermal keratinocytes by stimulating the ATM-dependent DNA repair pathway. Nonetheless, overexpression of WT-SMAD7 caused a susceptibility to 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperproliferation through activation of epidermal growth factor (EGF) signaling. In agreement with the transgenic mouse data, keratinocyte-specific deletion of SMAD7 markedly suppressed the tumor formation by inhibiting ATM and epidermal growth factor receptor (EGFR) signaling. Moreover, specific inhibition of EGFR signaling attenuated the hyperproliferation and tumor formation in TG-Smad7-WT mice. Taken together, these data support a novel role for SMAD7 as a tumor promoter in skin carcinogenesis where SMAD7 stimulates the DNA repair pathway and EGFR signaling activation.

     


    Author information

    Ha Thi HT1, Kim HY1, Lee YJ2, Kim SJ3, Hong S1.
    1
    Laboratory of Cancer Cell Biology, Department of Biochemistry, Gachon University School of Medicine, Incheon, Republic of Korea.
    2
    Laboratory of Developmental Genetics, Department of Biochemistry, Gachon University School of Medicine, Incheon, Republic of Korea.
    3
    Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Republic of Korea.

  • 덧글달기
    덧글달기
       IP : 3.17.6.75

    등록